Leuprolide 11.25mg Injection (GLIRIPI)

Leuprolide 11.25mg Injection (GLIRIPI) contains Leuprolide Acetate, a long-acting gonadotropin-releasing hormone (GnRH) agonist used to regulate the production of sex hormones. It is available as a depot formulation designed to provide prolonged hormonal suppression following administration by a qualified healthcare professional.

Leuprolide is used in the management of several hormone-dependent conditions, including certain prostate cancers, endometriosis, uterine fibroids, and central precocious puberty, depending on the specific formulation and indication.

Product Information

• Product Name: Leuprolide 11.25mg Injection (GLIRIPI)
• Generic Name: Leuprolide Acetate
• Strength: 11.25mg
• Dosage Form: Injection
• Manufacturer: Lyphilized
• Pack Size: 1 Injection
• Drug Class: GnRH Agonist
• Route: As directed by a healthcare professional

What is Leuprolide 11.25mg Injection Used For?

Leuprolide works by initially stimulating and subsequently suppressing the release of gonadotropins, resulting in reduced production of sex hormones. Depending on the formulation and clinical indication, leuprolide may be prescribed for:

• Certain types of prostate cancer
• Endometriosis
• Uterine fibroids
• Central precocious puberty
• Other hormone-dependent conditions when specifically prescribed by a specialist

For the 11.25mg three-month depot formulation, approved uses can vary by specific product and country. Patients should use GLIRIPI only for the condition prescribed by their healthcare provider.

How Does Leuprolide Work?

Leuprolide is a synthetic GnRH agonist. Following administration, it can initially cause a temporary increase in certain reproductive hormones. With continued exposure, GnRH receptor activity is suppressed, leading to decreased secretion of luteinizing hormone (LH) and follicle-stimulating hormone (FSH). This ultimately reduces circulating sex hormone levels.

This hormonal suppression is the basis for its therapeutic use in hormone-dependent diseases.

Leuprolide 11.25mg Dosage and Administration

Leuprolide 11.25mg depot formulations are generally intended for long-acting administration at approximately three-month intervals, depending on the specific product and indication. The FDA-approved 11.25mg depot formulation is administered as a single intramuscular injection by a healthcare provider and should not be substituted or divided with other leuprolide strengths.

The exact treatment schedule should be determined by the prescribing physician according to the patient’s condition, response to therapy, age, and other clinical factors.

Do not self-administer this medication unless specifically instructed and trained by a healthcare professional.

Possible Side Effects

Leuprolide may cause side effects because of its effects on hormone levels. Possible adverse effects can include:

• Hot flashes and sweating
• Headache
• Dizziness
• Nausea or vomiting
• Changes in libido
• Weight changes
• Mood changes
• Injection-site reactions
• Vaginal symptoms in women
• Temporary worsening or flare of symptoms after starting treatment

Long-term or repeated treatment may also affect bone mineral density. The prescribing information recommends appropriate monitoring and consideration of treatment duration depending on the indication.

Seek immediate medical attention for signs of a severe allergic reaction, serious skin reaction, severe neurological symptoms, or other serious or unusual reactions.

Important Precautions

Before receiving Leuprolide 11.25mg Injection, inform your doctor if you have:

• Osteoporosis or reduced bone density
• A history of seizures
• Heart disease or rhythm problems
• Electrolyte abnormalities
• Diabetes
• Previous stroke or cerebrovascular disease
• Depression or other significant mood disorders
• A history of allergic reactions to GnRH agonists

Leuprolide can cause an initial hormone surge after treatment begins, so some symptoms may temporarily worsen before hormonal suppression is established.

Pregnancy and Breastfeeding

Leuprolide should not be used during pregnancy unless specifically directed under an appropriate medical indication. It may cause fetal harm. Women who could become pregnant should discuss appropriate non-hormonal contraception with their healthcare provider.

Tell your doctor if you are pregnant, planning pregnancy, or breastfeeding before treatment.

Drug Interactions

Tell your doctor about all prescription medicines, over-the-counter medicines, vitamins, and supplements you are taking. Your healthcare provider should review your complete medication history before starting leuprolide therapy.

Particular caution may be required with medicines that affect heart rhythm or other treatments that influence hormonal or metabolic parameters.

Storage Information

Store Leuprolide 11.25mg Injection according to the product’s packaging and manufacturer instructions. Lyophilized depot formulations require appropriate handling and reconstitution before administration when applicable. The preparation should be administered by a qualified healthcare professional.

Why Choose Leuprolide 11.25mg Injection (GLIRIPI)?

Leuprolide 11.25mg Injection provides a long-acting hormonal treatment option for appropriate hormone-dependent conditions. Its depot formulation can reduce the need for frequent injections while providing sustained suppression of reproductive hormone activity when prescribed for an appropriate indication.

Frequently Asked Questions

What is Leuprolide 11.25mg Injection?

Leuprolide 11.25mg Injection contains leuprolide acetate, a GnRH agonist used to suppress the production of sex hormones in certain medical conditions.

How often is Leuprolide 11.25mg given?

The 11.25mg depot formulation is commonly designed for approximately three months of treatment, but the exact dosing schedule depends on the specific product and medical indication.

Who should administer Leuprolide Injection?

Leuprolide depot injections should be administered by a qualified healthcare professional according to the product instructions.

Can Leuprolide cause hormonal changes?

Yes. Leuprolide directly affects the body’s reproductive hormone system and initially may cause a temporary hormone increase before producing sustained hormonal suppression.

Is Leuprolide safe during pregnancy?

Leuprolide should not be used during pregnancy because it may cause fetal harm. Discuss pregnancy status and contraception with your healthcare provider before treatment.

Product Summary

Leuprolide 11.25mg Injection (GLIRIPI) is a long-acting Leuprolide Acetate injection used under medical supervision for appropriate hormone-dependent conditions. With its depot formulation, it provides prolonged hormonal suppression and is administered according to the prescribed treatment schedule.

Manufacturer: Lyphilized
Pack Size: 1 Injection
Strength: 11.25mg
Generic: Leuprolide Acetate

For genuine product availability and professional guidance, customers can explore MedicineWalyDost.com and consult a qualified healthcare professional before using this prescription medicine.